Next-Generation Sequencing (NGS) Market Expected to Grow at 24.4 Billion In Revenue by 2025

Next-Generation Sequencing (NGS) Market report provides analysis of top players in all regions with industry size, growth, technology, market insights, demand, trend, key statistics and industry forecasts to 2025.

The Next-Generation Sequencing (NGS) Market is projected to reach US$ 24.4 Billion by 2025 from US$ 7.8 Billion in 2019, at a CAGR of 20.9%. This report spread across 216 Pages, Profiling 20 Companies and Supported with 121 Tables and 39 figures is now available in this research.

Access Free Sample Report in PDF Format at https://www.reportsnreports.com/contacts/requestsample.aspx?name=508000

Major Vendors profiled in the Next-generation Sequencing (NGS) Market:
o Illumina Inc. (US)
o Thermo Fisher Scientific Inc. (US)
o BGI Group (China)
o PerkinElmer Inc. (US)
o Macrogen (South Korea)
o Hamilton Company (US)
o Lucigen (US)
o Intrexon Bioinformatics GmbH (Germany)
o Partek Incorporated (US)
o DNASTAR Inc. (US)
o DNAnexus (US)
o SciGenom Labs Pvt. Ltd. (India)
o GENEWIZ (US)
o Takara Bio Inc. (Japan)
o Eurofins Scientific (Luxembourg)
o 10x Genomics (US)

"The SBS segment accounted for the largest share of the NGS market in 2018."
On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina's systems, as it is the major provider of SBS-based NGS platforms (including the HiSeq MiSeq series and NextSeq).

"The diagnostics application segment accounted for the largest share of the NGS market in 2018."
Based on applications, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

Avail 20% Discount on this report at https://www.reportsnreports.com/contacts/discount.aspx?name=508000

Competitive Landscape of Next-generation Sequencing (NGS) Market:
1 Introduction
2 Competitive Leadership Mapping
2.1 Terminology/Nomenclature
2.1.1 Visionary Leaders
2.1.2 Innovators
2.1.3 Dynamic Differentiators
2.1.4 Emerging Companies
3 Competitive Scenario (2015-2019)
4 NGS Market Ranking, By Top Three Market Players (2018)

Research Coverage:
This report studies the NGS market based on product & service, technology, application, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micro markets with respect to their individual growth trends, prospects, and contributions to the total market.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

About Us:
ReportsnReports provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.